Trial intelligence / Profile preview

Amantadine or levodopa in vegetative state or minimally conscious state

ChiCTR-TRC-12002299Phase 2Completed

Sponsor
Xijing Hospital
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of amantadine and levodopa in vegetative state (VS) and Minimally conscious state (MCS) (3 arms), sponsored by Xijing Hospital. Primary endpoints: fMRI(BOLD) and EEG stimulating-reaction. Started Jul 2012; status: completed.

02

Drugs

amantadinelevodopa
03

Conditions

vegetative state (VS)Minimally conscious state (MCS)

Beyond the preview

Go deeper on ChiCTR-TRC-12002299.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call